In Brief: Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Medtronic: Commences overseas roll-out of the beStent 15mm balloon-expandable stent in Europe and "other world markets." The device utilizes a "serpentine mesh design" that provides "increased strength, scaffolding, and flexibility for the treatment of coronary lesions," Medtronic claims. The beStent also features radiopaque markers at the stent's ends to help physicians position the stent under fluoroscopy. The beStent launch follows the limited overseas release of the firm's Wiktor-i next generation Wiktor stent in October. The Wiktor-i balloon expandable stent for coronary angioplasty is available in 10-, 20- and 30-mm lengths to support lesion areas that may have required two or more 15 mm stents...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.